Vale Gerald Snowden OAM
It is with great sadness that SVI marks the passing of Gerald Snowden OAM, a treasured friend of the Institute. Gerald died on September 18, aged 93.
SVI research points the way to lasting benefit from promising type 1 diabetes tablet
A daily tablet that protects insulin production in people newly diagnosed with type 1 diabetes is likely to work best taken continuously rather than as a short course, new SVI research shows.
Professor Louise Purton elected President of international society
Professor Louise Purton has been appointed President of the International Society for Experimental Hematology (ISEH), the world's largest society devoted to experimental haematology.
SVI researchers awarded funding to tackle heart disease in Friedreich ataxia
SVI researchers have been awarded US$250,000 from the Friedreich’s Ataxia Research Alliance (FARA) to investigate new ways to understand and treat heart disease in people with Friedreich ataxia.
New funding to test gene editing repair for Bloom Syndrome
SVI researchers have been awarded a grant from the US-based Bloom Syndrome Association to investigate a gene editing approach that could one day lead to better treatments for the condition.
Research explores new way to protect the heart during cancer treatment
SVI researchers have identified a promising new approach that could one day help protect the heart from the damaging side effects of some cancer treatments.
Professor Fabienne Mackay begins as SVI’s fifth Director
SVI today welcomes Professor Fabienne Mackay as our new Director, only the fifth person to lead the Institute in its 68-year history.
Study reveals gaps in diversity and reporting across global genomics databases
A new international study, led by Associate Professor Irene Gallego Romero, has revealed gaps in how human diversity is represented and reported in some of the world's largest public genomics databases.